期刊文献+

儿童口服液体药物制剂的技术难点及研发策略分析 被引量:19

Analysis of technical difficulties and new strategies of oral liquid pharmaceutical preparation for children
原文传递
导出
摘要 随着二胎生育政策落实和儿童健康用药需求的不断增长,儿童用药问题引起国家和社会的广泛关注,儿童药物新品种、新规格和新剂型的研发是药学研究工作者和制药企业面临的迫切任务。本文围绕口服药物液体制剂研发中存在药物溶解性、液体制剂稳定性、辅料安全性和服药的顺应性等技术难点,对已上市儿童口服药物液体制剂的技术特征和目前研究所涉及的药物纳米晶体、自微乳、离子交换树脂和Pickering乳剂等新技术在儿童药物液体制剂的研究情况进行讨论分析,以期对儿童口服药物液体制剂的研究开发起到理论指导作用。 With the implementation of the two-child policy and the growing demand for child health,pediatric medication has been arousing widespread social concern.To develop the drugs suitable for children,including new compounds,new specifications and new dosage forms,is urgently required for pharmaceutical researchers.In this review,several technical bottlenecks for pediatric oral liquid preparations,as well as the novel strategies involved in drug nanocrystals,self-microemulsion,ion exchange resin and Pickering emulsion were discussed,which may be benefit to play a theoretical guiding role in the research and development of children's oral liquid formulation.
作者 陈鑫 卢安 王向宇 王晓玲 郑爱萍 王坚成 CHEN Xin;LU An;WANG Xiang-yu;WANG Xiao-ling;ZHENG Ai-ping;WANG Jian-cheng(School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;Beijing Children's Hospital,Capital Medical University,Beijing 100045,China;Institute of Pharmacology and Toxicology of the Academy of Military Medical Sciences,Beijing 100850,China)
出处 《药学学报》 CAS CSCD 北大核心 2021年第1期130-137,共8页 Acta Pharmaceutica Sinica
基金 国家重大新药创制科技重大专项资助项目(2018ZX09721003-004).
关键词 口服药物 儿科学 液体药物制剂 乳剂 离子交换树脂 oral drug administration pediatrics liquid pharmaceutical preparation emulsion ion exchange resin
  • 相关文献

参考文献2

二级参考文献26

  • 1张志华,何周康,吴浩.药品说明书中有关儿童用药内容的调查[J].儿科药学杂志,2004,10(5):41-42. 被引量:33
  • 2倪韶青,寿洪初,王珏.关于儿童用药的问题及建议[J].中国医院药学杂志,2007,27(6):815-817. 被引量:43
  • 3中华人民共和国国家统计局.2010年第六次全国人口普查主要数据公报[EB/OL].(2011-04-28)[2011-08-22].http://www.stats.gov.cn/tjgb/rkpcgb/qgrkpcgb/t20110428_402722232.htm. 被引量:26
  • 4陈贵廷,薛赛琴. 最新国外疾病诊断标准[M]. 北京:学苑出版社,1991:209-211,214-215. 被引量:5
  • 5Tauzin B. 2010 report: medicine in development for children [R/OL]. [2013-04-15].USA: PhRMA, 2010: 1-36. http://www. phrma, org/sites/de fault/files/422/children2010 .pdf. 被引量:1
  • 6Waisel DB. Moral responsibility to attain thorough pediatric drug labeling[J]. Paediatr Anaesth, 2009,19 (10) : 989-993. 被引量:1
  • 7Napoleone E. Children and ADRs (Adverse Drug Reactions )[J]. Ital J Pediatr, 2010,36 : 4. 被引量:1
  • 8Kling S. Off- label drug use in childhood asthma[J]. Current Al- lergy & Clinical Immunology, 2011,24( 1 ) :38-41. 被引量:1
  • 9Bavdekar SB, Gogtay NJ. Unlicensed and off-label drug use in children[J]. J Postgrad Med, 2005,51 (4) : 249-252. 被引量:1
  • 10Woods D, Thomas E, Holl J, et al. Adverse events and pre- ventable adverse events in children [J]. Pediatrics, 2005,115 : ! ) : 155-160. 被引量:1

共引文献75

同被引文献252

引证文献19

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部